dsip Buy DSIP (Delta Sleep-Inducing Peptide) –

What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

Not for human or veterinary use.

The molecule contains a modified amino acid sequence derived from the glucagon backbone and includes substitutions designed to improve resistance to enzymatic degradation while preserving receptor binding functionality

The peptide rapidly normalizes intraocular pressure and preserves the integrity of retinal ganglion cells and optic nerves

S.BenedictJ